SMO Clinplus Co Ltd
SZSE:301257
Relative Value
The Relative Value of one SMO Clinplus Co Ltd stock under the Base Case scenario is 35.33 CNY. Compared to the current market price of 67.99 CNY, SMO Clinplus Co Ltd is Overvalued by 48%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
SMO Clinplus Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
SMO Clinplus Co Ltd
SZSE:301257
|
5.4B CNY | 6.8 | 51.2 | 43.1 | 43.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 370.3 | 4 385.2 | 1 390.4 | 2 970.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
194.7B USD | 4.4 | 29.2 | 20.3 | 27.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
147.8B USD | 6 | 40.9 | 22.7 | 34.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 14.4 | 49.6 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.5B CHF | 5.6 | 38.6 | 28.5 | 28.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
282.1B CNY | 6.3 | 18.7 | 18.9 | 18.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.6B USD | 4.9 | 25.9 | 19 | 22.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28B USD | 7 | 32.3 | 23.8 | 26.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.8B USD | 1.8 | 21.2 | 11.8 | 17.7 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
162.2B HKD | 7.1 | 34.1 | 23.9 | 23.9 |